Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients – Early Results of a Phase II Trial

Glioblastoma Multiforme (GBM) is an aggressive primary brain neoplasm with dismal prognosis. Based on successful phase III trials, 60 Gy involved-field radiotherapy in 30 fractions over 6 weeks [Standard radiation therapy (RT)] with concurrent and adjuvant temozolomide is currently the standard of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Floyd, Scott R., Kasper, Ekkehard M., Uhlmann, Erik J., Fonkem, Ekokobe, Wong, Eric T., Mahadevan, Anand
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2012
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472503/
https://ncbi.nlm.nih.gov/pubmed/23087896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00122
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados